Skip to main content
Clinical Trials/ACTRN12608000265370
ACTRN12608000265370
Not yet recruiting
未知

Quantifying physiological skin changes and quality of life in oncology patients on epidermal growth factor receptor inhibitors (EGFRIs) compared to normal participants not on EGFRIs. Can physiological skin changes be used to quantify cutaneous toxicities and evaluate subclinical changes before overt disease in order to prevent and minimise these side effects.

inda Wang0 sites15 target enrollmentMay 26, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Cutaneous side effects on oncology patients on EGFRIs
Sponsor
inda Wang
Enrollment
15
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
inda Wang

Eligibility Criteria

Inclusion Criteria

  • Oncology patients about to start EGFRIs
  • male or female
  • aged 18 years or above
  • willing to give informed consent

Exclusion Criteria

  • Younger than 18 years of age
  • severe underlying disease that may interfere with the testing or test results

Outcomes

Primary Outcomes

Not specified

Similar Trials